Pablo Jiménez (@pauljil) 's Twitter Profile
Pablo Jiménez

@pauljil

Medical Oncologist. MD MSc. Clinical Research Fellow. The Royal Marsden NHS Foundation Trust. Interested in HN&GU,Early phase Clinical Trials! Tweets my own.

ID: 303180415

calendar_today22-05-2011 12:42:30

247 Tweet

269 Followers

590 Following

Pablo Jiménez (@pauljil) 's Twitter Profile Photo
Pablo Jiménez
@pauljil

6 months ago

🚨Neo and adjuvant pembrolizumab for patients with resectable head and neck squamous cell carcinoma (KEYNOTE689) is now published in NEJM 💥Great step forward in the field Awaiting OS in next interim analyses Will NIVOPOSTOP be approved by FDA as well? U.S. FDA What would be

🚨Neo and adjuvant pembrolizumab for patients with resectable head and neck squamous cell carcinoma (KEYNOTE689) is now published in <a href="/NEJM/">NEJM</a> 💥Great step forward in the field Awaiting OS in next interim analyses Will NIVOPOSTOP be approved by FDA as well? <a href="/US_FDA/">U.S. FDA</a> What would be